Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Biotherapies in Uveitis (BioÚvea) Study Group"'
Autor:
Llorenç, Victor, Cordero-Coma, Miguel, Blanco-Esteban, Ana, Heras-Mulero, Henar, Losada-Castillo, María-José, Jovani-Casano, Vega, Valls-Pascual, Elia, Jodar-Marquez, Margarita, García-Aparicio, Ángel, Fonollosa, Alejandro, González-Guijarro, Juan Jacobo, Rodriguez-Melian, Luís, Fernández-Prada, Manuel, Jerez-Fidalgo, María, Hernandez-Garfella, Marisa, Esquinas, Cristina, Sainz-de-la-Maza, Maite, Adán, Alfredo
Publikováno v:
In Ophthalmology June 2020 127(6):814-825
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Llorenç, Victor, Cordero-Coma, Miguel, Blanco-Esteban, Ana, Heras-Mulero, Henar, Losada-Castillo, María-José, Jovani-Casano, Vega, Valls-Pascual, Elia, Jodar-Marquez, Margarita, García-Aparicio, Ángel, Fonollosa, Alejandro, González-Guijarro, Juan Jacobo, Rodriguez-Melian, Luís, Fernández-Prada, Manuel, Jerez-Fidalgo, María, Hernandez-Garfella, Marisa, Esquinas, Cristina, Sainz-de-la-Maza, Maite, Adán, Alfredo, Biotherapies in Uveitis (BioÚvea) Study Group
To study the drug retention rate (DRR), causes, and predictors of discontinuation of adalimumab (ADA) in a real-world uveitis setting. Multicentric, nationwide, registry-based, ambispective, observational study. Patients treated with ADA for noninfec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2636::1b6f4df73c3d76eded64dd9bc3e6b5dc
https://hdl.handle.net/10668/14966
https://hdl.handle.net/10668/14966
Autor:
Victor, Llorenç, Miguel, Cordero-Coma, Ana, Blanco-Esteban, Henar, Heras-Mulero, María-José, Losada-Castillo, Vega, Jovani-Casano, Elia, Valls-Pascual, Margarita, Jodar-Marquez, Ángel, García-Aparicio, Alejandro, Fonollosa, Juan Jacobo, González-Guijarro, Luís, Rodriguez-Melian, Manuel, Fernández-Prada, María, Jerez-Fidalgo, Marisa, Hernandez-Garfella, Cristina, Esquinas, Maite, Sainz-de-la-Maza, Alfredo, Adán
Publikováno v:
Ophthalmology. 127(6)
To study the drug retention rate (DRR), causes, and predictors of discontinuation of adalimumab (ADA) in a real-world uveitis setting.Multicentric, nationwide, registry-based, ambispective, observational study.Patients treated with ADA for noninfecti
Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease – A Case Series.
Autor:
Hamdan, Abel1 (AUTHOR), Sharma, Sumit1 (AUTHOR), Baynes, Kimberly1 (AUTHOR), Hajj Ali, Rula A.2 (AUTHOR), Lowder, Careen Y.1 (AUTHOR), Srivastava, Sunil K.1 (AUTHOR) srivass2@ccf.org
Publikováno v:
Journal of Ophthalmic Inflammation & Infection. 7/30/2024, Vol. 14 Issue 1, p1-8. 8p.
Autor:
Zhang, Zheting1 (AUTHOR), Ng Ming Sheng, Sean1 (AUTHOR), Kempen, John H.2,3,4,5 (AUTHOR), Fabiani, Claudia6 (AUTHOR), Arora, Atul7 (AUTHOR), Gupta, Vishali7 (AUTHOR), Tsui, Edmund8 (AUTHOR), Cimino, Luca9,10 (AUTHOR), Symes, Richard J.11 (AUTHOR), Dell, Jennifer12 (AUTHOR), Finger, Robert P.12 (AUTHOR), Heinz, Carsten13,14 (AUTHOR), Agrawal, Rupesh1,15,16,17,18 (AUTHOR) rupesh_agrawal@ttsh.com.sg
Publikováno v:
Ocular Immunology & Inflammation. Nov2023, Vol. 31 Issue 9, p1859-1869. 11p.
Autor:
McKay, K. Matthew1,2 (AUTHOR), Apostolopoulos, Nicholas3 (AUTHOR), Chou, Brian1 (AUTHOR), Leveque, Thellea K.1 (AUTHOR), Van Gelder, Russell N.1,2,4,5 (AUTHOR) russvg@uw.edu
Publikováno v:
Ocular Immunology & Inflammation. Oct/Nov2022, Vol. 30 Issue 7/8, p1721-1725. 5p.
Autor:
Hernanz, I.1 (AUTHOR) ines.hernanz.ro@gmail.com, Miguel Escuder, L.1 (AUTHOR), Chamorro, L.1 (AUTHOR), Moll-Udina, A1,2 (AUTHOR), Espinosa, G.1,2 (AUTHOR), Sainz de la Maza, M.1,2 (AUTHOR), Llorenç, V.1,2 (AUTHOR), Adán, A.1,2 (AUTHOR)
Publikováno v:
Ocular Immunology & Inflammation. 2022, Vol. 30 Issue 4, p839-844. 6p.
Publikováno v:
Computational & Mathematical Methods in Medicine. 9/6/2021, p1-7. 7p.